nodes	percent_of_prediction	percent_of_DWPC	metapath
Tacrolimus—ALB—membranous glomerulonephritis	0.835	1	CbGaD
Tacrolimus—ABCA5—nephron tubule—membranous glomerulonephritis	0.013	0.129	CbGeAlD
Tacrolimus—ABCA5—cortex of kidney—membranous glomerulonephritis	0.0112	0.11	CbGeAlD
Tacrolimus—PPP3CA—nephron tubule—membranous glomerulonephritis	0.0088	0.0869	CbGeAlD
Tacrolimus—PPP3CA—kidney—membranous glomerulonephritis	0.00774	0.0764	CbGeAlD
Tacrolimus—PPP3CA—cortex of kidney—membranous glomerulonephritis	0.00754	0.0744	CbGeAlD
Tacrolimus—MTOR—epithelium—membranous glomerulonephritis	0.00637	0.0629	CbGeAlD
Tacrolimus—CYP3A7-CYP3A51P—nephron tubule—membranous glomerulonephritis	0.00615	0.0607	CbGeAlD
Tacrolimus—FKBP1A—epithelium—membranous glomerulonephritis	0.00573	0.0566	CbGeAlD
Tacrolimus—MTOR—kidney—membranous glomerulonephritis	0.00572	0.0564	CbGeAlD
Tacrolimus—CYP3A7-CYP3A51P—cortex of kidney—membranous glomerulonephritis	0.00527	0.052	CbGeAlD
Tacrolimus—FKBP1A—kidney—membranous glomerulonephritis	0.00514	0.0507	CbGeAlD
Tacrolimus—FKBP1A—cortex of kidney—membranous glomerulonephritis	0.00501	0.0494	CbGeAlD
Tacrolimus—CYP3A5—nephron tubule—membranous glomerulonephritis	0.00255	0.0251	CbGeAlD
Tacrolimus—MTOR—SREBF and miR33 in cholesterol and lipid homeostasis—ABCA1—membranous glomerulonephritis	0.00244	0.038	CbGpPWpGaD
Tacrolimus—CYP3A5—kidney—membranous glomerulonephritis	0.00224	0.0221	CbGeAlD
Tacrolimus—CYP3A5—cortex of kidney—membranous glomerulonephritis	0.00218	0.0215	CbGeAlD
Tacrolimus—FKBP1A—TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)—RHOA—membranous glomerulonephritis	0.00216	0.0336	CbGpPWpGaD
Tacrolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—CD40LG—membranous glomerulonephritis	0.00215	0.0335	CbGpPWpGaD
Tacrolimus—PPP3CA—Physiological and Pathological Hypertrophy  of the Heart—RHOA—membranous glomerulonephritis	0.00195	0.0303	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by SCF-KIT—PTPRU—membranous glomerulonephritis	0.00187	0.0291	CbGpPWpGaD
Tacrolimus—PPP3CA—BCR signaling pathway—CD79A—membranous glomerulonephritis	0.00174	0.0272	CbGpPWpGaD
Tacrolimus—CYP3A4—kidney—membranous glomerulonephritis	0.00168	0.0166	CbGeAlD
Tacrolimus—ABCB1—nephron tubule—membranous glomerulonephritis	0.00135	0.0134	CbGeAlD
Tacrolimus—ABCB1—epithelium—membranous glomerulonephritis	0.00133	0.0131	CbGeAlD
Tacrolimus—ALB—HDL-mediated lipid transport—ABCA1—membranous glomerulonephritis	0.00126	0.0196	CbGpPWpGaD
Tacrolimus—ABCB1—kidney—membranous glomerulonephritis	0.00119	0.0117	CbGeAlD
Tacrolimus—CYP3A7—Cytochrome P450 - arranged by substrate type—TBXAS1—membranous glomerulonephritis	0.00116	0.0181	CbGpPWpGaD
Tacrolimus—ABCB1—cortex of kidney—membranous glomerulonephritis	0.00116	0.0114	CbGeAlD
Tacrolimus—PPP3CA—Alzheimers Disease—APOE—membranous glomerulonephritis	0.00102	0.016	CbGpPWpGaD
Tacrolimus—CYP3A7—Phase 1 - Functionalization of compounds—TBXAS1—membranous glomerulonephritis	0.000943	0.0147	CbGpPWpGaD
Tacrolimus—ALB—Scavenging of heme from plasma—APOA1—membranous glomerulonephritis	0.000919	0.0143	CbGpPWpGaD
Tacrolimus—CYP3A5—Cytochrome P450 - arranged by substrate type—TBXAS1—membranous glomerulonephritis	0.00084	0.0131	CbGpPWpGaD
Tacrolimus—ALB—HDL-mediated lipid transport—APOE—membranous glomerulonephritis	0.000829	0.0129	CbGpPWpGaD
Tacrolimus—ALB—HDL-mediated lipid transport—APOA1—membranous glomerulonephritis	0.000819	0.0128	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—C7—membranous glomerulonephritis	0.000749	0.0117	CbGpPWpGaD
Tacrolimus—PPP3CA—MicroRNAs in cardiomyocyte hypertrophy—RHOA—membranous glomerulonephritis	0.000738	0.0115	CbGpPWpGaD
Tacrolimus—ALB—Vitamin B12 Metabolism—LRP2—membranous glomerulonephritis	0.000735	0.0115	CbGpPWpGaD
Tacrolimus—ALB—Lipoprotein metabolism—ABCA1—membranous glomerulonephritis	0.000724	0.0113	CbGpPWpGaD
Tacrolimus—MTOR—Costimulation by the CD28 family—HLA-DQA1—membranous glomerulonephritis	0.000693	0.0108	CbGpPWpGaD
Tacrolimus—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SPARC—membranous glomerulonephritis	0.000692	0.0108	CbGpPWpGaD
Tacrolimus—CYP3A5—Phase 1 - Functionalization of compounds—TBXAS1—membranous glomerulonephritis	0.000681	0.0106	CbGpPWpGaD
Tacrolimus—PPP3CA—G Protein Signaling Pathways—RHOA—membranous glomerulonephritis	0.00068	0.0106	CbGpPWpGaD
Tacrolimus—MTOR—Alpha 6 Beta 4 signaling pathway—RHOA—membranous glomerulonephritis	0.00068	0.0106	CbGpPWpGaD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—SPARC—membranous glomerulonephritis	0.000663	0.0103	CbGpPWpGaD
Tacrolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—RHOA—membranous glomerulonephritis	0.000662	0.0103	CbGpPWpGaD
Tacrolimus—MTOR—IL4-mediated signaling events—CD40LG—membranous glomerulonephritis	0.000659	0.0103	CbGpPWpGaD
Tacrolimus—PPP3CA—Alzheimers Disease—IL1B—membranous glomerulonephritis	0.000653	0.0102	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—CFH—membranous glomerulonephritis	0.000594	0.00926	CbGpPWpGaD
Tacrolimus—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—membranous glomerulonephritis	0.000574	0.00894	CbGpPWpGaD
Tacrolimus—PPP3CA—Spinal Cord Injury—RHOA—membranous glomerulonephritis	0.000562	0.00877	CbGpPWpGaD
Tacrolimus—MTOR—IL12-mediated signaling events—HLA-DRB1—membranous glomerulonephritis	0.000545	0.00849	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—PTPRU—membranous glomerulonephritis	0.000523	0.00815	CbGpPWpGaD
Tacrolimus—CYP3A7—Biological oxidations—TBXAS1—membranous glomerulonephritis	0.000501	0.0078	CbGpPWpGaD
Tacrolimus—MTOR—Costimulation by the CD28 family—HLA-DRB1—membranous glomerulonephritis	0.000493	0.00768	CbGpPWpGaD
Tacrolimus—PPP3CA—beta-catenin independent WNT signaling—RHOA—membranous glomerulonephritis	0.000482	0.00752	CbGpPWpGaD
Tacrolimus—ALB—Lipid and lipoprotein metabolism—ABCA1—membranous glomerulonephritis	0.000481	0.0075	CbGpPWpGaD
Tacrolimus—ALB—Lipoprotein metabolism—APOE—membranous glomerulonephritis	0.000476	0.00742	CbGpPWpGaD
Tacrolimus—PPP3CA—Spinal Cord Injury—IL1B—membranous glomerulonephritis	0.000474	0.00738	CbGpPWpGaD
Tacrolimus—ALB—Vitamin B12 Metabolism—ABCA1—membranous glomerulonephritis	0.000473	0.00738	CbGpPWpGaD
Tacrolimus—MTOR—Wnt Signaling Pathway Netpath—RHOA—membranous glomerulonephritis	0.000472	0.00736	CbGpPWpGaD
Tacrolimus—ALB—Lipoprotein metabolism—APOA1—membranous glomerulonephritis	0.000471	0.00734	CbGpPWpGaD
Tacrolimus—MTOR—IFN-gamma pathway—IL1B—membranous glomerulonephritis	0.000463	0.00722	CbGpPWpGaD
Tacrolimus—PPP3CA—Spinal Cord Injury—MMP9—membranous glomerulonephritis	0.000447	0.00696	CbGpPWpGaD
Tacrolimus—ALB—Vitamin B12 Metabolism—PLG—membranous glomerulonephritis	0.00044	0.00686	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—C7—membranous glomerulonephritis	0.000436	0.0068	CbGpPWpGaD
Tacrolimus—FKBP1A—Spinal Cord Injury—RHOA—membranous glomerulonephritis	0.000436	0.0068	CbGpPWpGaD
Tacrolimus—MTOR—CXCR4-mediated signaling events—HLA-DRB1—membranous glomerulonephritis	0.000416	0.00649	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—PTPRU—membranous glomerulonephritis	0.000405	0.00632	CbGpPWpGaD
Tacrolimus—ALB—Platelet degranulation—SPARC—membranous glomerulonephritis	0.000405	0.00632	CbGpPWpGaD
Tacrolimus—CYP3A4—Cytochrome P450 - arranged by substrate type—TBXAS1—membranous glomerulonephritis	0.000391	0.00609	CbGpPWpGaD
Tacrolimus—ALB—Response to elevated platelet cytosolic Ca2+—SPARC—membranous glomerulonephritis	0.000386	0.00602	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—ABCA1—membranous glomerulonephritis	0.000385	0.006	CbGpPWpGaD
Tacrolimus—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—membranous glomerulonephritis	0.000371	0.00578	CbGpPWpGaD
Tacrolimus—FKBP1A—Spinal Cord Injury—IL1B—membranous glomerulonephritis	0.000367	0.00572	CbGpPWpGaD
Tacrolimus—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOA1—membranous glomerulonephritis	0.000367	0.00571	CbGpPWpGaD
Tacrolimus—CYP3A5—Biological oxidations—TBXAS1—membranous glomerulonephritis	0.000362	0.00564	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—PLG—membranous glomerulonephritis	0.000358	0.00558	CbGpPWpGaD
Tacrolimus—PPP3CA—MAPK Signaling Pathway—IL1B—membranous glomerulonephritis	0.000357	0.00557	CbGpPWpGaD
Tacrolimus—ABCB1—ABC-family proteins mediated transport—APOA1—membranous glomerulonephritis	0.000356	0.00556	CbGpPWpGaD
Tacrolimus—MTOR—IL12-mediated signaling events—IL1B—membranous glomerulonephritis	0.000355	0.00553	CbGpPWpGaD
Tacrolimus—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—membranous glomerulonephritis	0.000353	0.00551	CbGpPWpGaD
Tacrolimus—MTOR—Leptin signaling pathway—RHOA—membranous glomerulonephritis	0.000352	0.00549	CbGpPWpGaD
Tacrolimus—ALB—FOXA2 and FOXA3 transcription factor networks—APOA1—membranous glomerulonephritis	0.000346	0.0054	CbGpPWpGaD
Tacrolimus—FKBP1A—Spinal Cord Injury—MMP9—membranous glomerulonephritis	0.000346	0.0054	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CFH—membranous glomerulonephritis	0.000346	0.00539	CbGpPWpGaD
Tacrolimus—MTOR—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—RHOA—membranous glomerulonephritis	0.000335	0.00522	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—C7—membranous glomerulonephritis	0.000327	0.00509	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by PDGF—PLG—membranous glomerulonephritis	0.000324	0.00505	CbGpPWpGaD
Tacrolimus—MTOR—B Cell Activation—CD79A—membranous glomerulonephritis	0.000323	0.00504	CbGpPWpGaD
Tacrolimus—MTOR—CXCR4-mediated signaling events—RHOA—membranous glomerulonephritis	0.000322	0.00502	CbGpPWpGaD
Tacrolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—RHOA—membranous glomerulonephritis	0.000322	0.00502	CbGpPWpGaD
Tacrolimus—CYP3A4—Phase 1 - Functionalization of compounds—TBXAS1—membranous glomerulonephritis	0.000317	0.00494	CbGpPWpGaD
Tacrolimus—ALB—Lipid and lipoprotein metabolism—APOE—membranous glomerulonephritis	0.000316	0.00493	CbGpPWpGaD
Tacrolimus—ALB—Lipid and lipoprotein metabolism—APOA1—membranous glomerulonephritis	0.000313	0.00488	CbGpPWpGaD
Tacrolimus—ALB—Vitamin B12 Metabolism—APOE—membranous glomerulonephritis	0.000311	0.00485	CbGpPWpGaD
Tacrolimus—ALB—Vitamin B12 Metabolism—APOA1—membranous glomerulonephritis	0.000308	0.0048	CbGpPWpGaD
Tacrolimus—ALB—Platelet degranulation—PLG—membranous glomerulonephritis	0.000307	0.00479	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—ABCA1—membranous glomerulonephritis	0.000306	0.00477	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—CD40—membranous glomerulonephritis	0.000305	0.00475	CbGpPWpGaD
Tacrolimus—MTOR—Leptin signaling pathway—IL1B—membranous glomerulonephritis	0.000297	0.00463	CbGpPWpGaD
Tacrolimus—ALB—Response to elevated platelet cytosolic Ca2+—PLG—membranous glomerulonephritis	0.000292	0.00456	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—PLG—membranous glomerulonephritis	0.000284	0.00443	CbGpPWpGaD
Tacrolimus—MTOR—PI3K/AKT activation—RHOA—membranous glomerulonephritis	0.000278	0.00433	CbGpPWpGaD
Tacrolimus—MTOR—VEGFA-VEGFR2 Pathway—RHOA—membranous glomerulonephritis	0.000265	0.00413	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—LRP2—membranous glomerulonephritis	0.000265	0.00413	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—HLA-DQA1—membranous glomerulonephritis	0.000265	0.00412	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—CFH—membranous glomerulonephritis	0.000259	0.00404	CbGpPWpGaD
Tacrolimus—MTOR—CXCR4-mediated signaling events—MMP9—membranous glomerulonephritis	0.000256	0.00398	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by Wnt—RHOA—membranous glomerulonephritis	0.000255	0.00398	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—APOA1—membranous glomerulonephritis	0.00025	0.0039	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by VEGF—RHOA—membranous glomerulonephritis	0.00025	0.0039	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—CD40LG—membranous glomerulonephritis	0.000234	0.00364	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PTPRU—membranous glomerulonephritis	0.000228	0.00355	CbGpPWpGaD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—IL1B—membranous glomerulonephritis	0.000227	0.00353	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—C3—membranous glomerulonephritis	0.000224	0.00349	CbGpPWpGaD
Tacrolimus—ALB—Platelet degranulation—APOA1—membranous glomerulonephritis	0.000215	0.00335	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—C3—membranous glomerulonephritis	0.000207	0.00322	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—LRP2—membranous glomerulonephritis	0.000205	0.0032	CbGpPWpGaD
Tacrolimus—ALB—Response to elevated platelet cytosolic Ca2+—APOA1—membranous glomerulonephritis	0.000205	0.00319	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—APOA1—membranous glomerulonephritis	0.000199	0.0031	CbGpPWpGaD
Tacrolimus—ALB—Vitamin B12 Metabolism—IL1B—membranous glomerulonephritis	0.000199	0.00309	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CD40—membranous glomerulonephritis	0.000193	0.003	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—C7—membranous glomerulonephritis	0.00019	0.00297	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—HLA-DRB1—membranous glomerulonephritis	0.000188	0.00293	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—LRP2—membranous glomerulonephritis	0.000185	0.00289	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CD79A—membranous glomerulonephritis	0.000181	0.00282	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—SPARC—membranous glomerulonephritis	0.00018	0.0028	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by SCF-KIT—MMP9—membranous glomerulonephritis	0.000169	0.00263	CbGpPWpGaD
Tacrolimus—CYP3A4—Biological oxidations—TBXAS1—membranous glomerulonephritis	0.000168	0.00262	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—HLA-DQA1—membranous glomerulonephritis	0.000167	0.00261	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—IL1B—membranous glomerulonephritis	0.000162	0.00252	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—RHOA—membranous glomerulonephritis	0.000157	0.00245	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CFH—membranous glomerulonephritis	0.000151	0.00235	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CD40LG—membranous glomerulonephritis	0.000148	0.0023	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—LRP2—membranous glomerulonephritis	0.000144	0.00224	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—C3—membranous glomerulonephritis	0.000143	0.00223	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—CD40—membranous glomerulonephritis	0.000139	0.00216	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—PLG—membranous glomerulonephritis	0.000136	0.00212	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—C3—membranous glomerulonephritis	0.000131	0.00204	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—CD79A—membranous glomerulonephritis	0.00013	0.00203	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—IL1B—membranous glomerulonephritis	0.000128	0.002	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—IL1B—membranous glomerulonephritis	0.000123	0.00191	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—RHOA—membranous glomerulonephritis	0.000121	0.00188	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—HLA-DQA1—membranous glomerulonephritis	0.00012	0.00187	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—TBXAS1—membranous glomerulonephritis	0.00012	0.00187	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—HLA-DRB1—membranous glomerulonephritis	0.000119	0.00185	CbGpPWpGaD
Tacrolimus—MTOR—Disease—LRP2—membranous glomerulonephritis	0.000115	0.0018	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—APOE—membranous glomerulonephritis	0.000112	0.00175	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—PLG—membranous glomerulonephritis	0.000111	0.00173	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—APOA1—membranous glomerulonephritis	0.000111	0.00173	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—LRP2—membranous glomerulonephritis	0.000107	0.00166	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—CD40LG—membranous glomerulonephritis	0.000106	0.00166	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PLA2G1B—membranous glomerulonephritis	0.000103	0.0016	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—RHOA—membranous glomerulonephritis	0.000101	0.00157	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—C3—membranous glomerulonephritis	9.78e-05	0.00152	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—APOA1—membranous glomerulonephritis	9.52e-05	0.00148	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—C3—membranous glomerulonephritis	9.39e-05	0.00146	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—SPARC—membranous glomerulonephritis	9.26e-05	0.00144	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—APOE—membranous glomerulonephritis	8.7e-05	0.00136	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—PLG—membranous glomerulonephritis	8.61e-05	0.00134	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—APOA1—membranous glomerulonephritis	8.6e-05	0.00134	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—TBXAS1—membranous glomerulonephritis	8.56e-05	0.00133	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—HLA-DRB1—membranous glomerulonephritis	8.55e-05	0.00133	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—RHOA—membranous glomerulonephritis	8.49e-05	0.00132	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—C3—membranous glomerulonephritis	8.44e-05	0.00132	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD40—membranous glomerulonephritis	8.41e-05	0.00131	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—LRP2—membranous glomerulonephritis	8.09e-05	0.00126	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD79A—membranous glomerulonephritis	7.9e-05	0.00123	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—APOE—membranous glomerulonephritis	7.86e-05	0.00123	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—APOA1—membranous glomerulonephritis	7.77e-05	0.00121	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IL1B—membranous glomerulonephritis	7.75e-05	0.00121	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—LRP2—membranous glomerulonephritis	7.63e-05	0.00119	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PLA2G1B—membranous glomerulonephritis	7.35e-05	0.00115	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—RHOA—membranous glomerulonephritis	7.29e-05	0.00114	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—HLA-DQA1—membranous glomerulonephritis	7.29e-05	0.00114	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—PLG—membranous glomerulonephritis	7.02e-05	0.00109	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	6.87e-05	0.00107	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—RHOA—membranous glomerulonephritis	6.59e-05	0.00103	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—C3—membranous glomerulonephritis	6.55e-05	0.00102	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD40LG—membranous glomerulonephritis	6.44e-05	0.001	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—TBXAS1—membranous glomerulonephritis	6.19e-05	0.000965	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—APOE—membranous glomerulonephritis	6.09e-05	0.00095	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—PLG—membranous glomerulonephritis	6.08e-05	0.000947	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—APOA1—membranous glomerulonephritis	6.02e-05	0.000939	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—RHOA—membranous glomerulonephritis	5.95e-05	0.000927	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—C3—membranous glomerulonephritis	5.69e-05	0.000888	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—LRP2—membranous glomerulonephritis	5.52e-05	0.00086	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—TBXAS1—membranous glomerulonephritis	5.33e-05	0.000831	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—PLG—membranous glomerulonephritis	5.32e-05	0.00083	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PLA2G1B—membranous glomerulonephritis	5.31e-05	0.000828	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—HLA-DRB1—membranous glomerulonephritis	5.19e-05	0.000809	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—ABCA1—membranous glomerulonephritis	4.92e-05	0.000767	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—APOA1—membranous glomerulonephritis	4.91e-05	0.000765	CbGpPWpGaD
Tacrolimus—MTOR—Disease—APOE—membranous glomerulonephritis	4.89e-05	0.000763	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PLG—membranous glomerulonephritis	4.84e-05	0.000755	CbGpPWpGaD
Tacrolimus—MTOR—Disease—APOA1—membranous glomerulonephritis	4.84e-05	0.000754	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—LRP2—membranous glomerulonephritis	4.75e-05	0.000741	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—MMP9—membranous glomerulonephritis	4.72e-05	0.000736	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—TBXAS1—membranous glomerulonephritis	4.67e-05	0.000728	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—RHOA—membranous glomerulonephritis	4.61e-05	0.000719	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PLA2G1B—membranous glomerulonephritis	4.57e-05	0.000713	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	4.52e-05	0.000705	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	4.47e-05	0.000697	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—APOA1—membranous glomerulonephritis	4.25e-05	0.000663	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—LRP2—membranous glomerulonephritis	4.16e-05	0.000649	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PLA2G1B—membranous glomerulonephritis	4.01e-05	0.000625	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—RHOA—membranous glomerulonephritis	3.76e-05	0.000586	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—APOA1—membranous glomerulonephritis	3.72e-05	0.000581	CbGpPWpGaD
Tacrolimus—MTOR—Disease—RHOA—membranous glomerulonephritis	3.7e-05	0.000577	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—C3—membranous glomerulonephritis	3.68e-05	0.000574	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—MMP9—membranous glomerulonephritis	3.66e-05	0.000571	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ABCA1—membranous glomerulonephritis	3.55e-05	0.000554	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—APOE—membranous glomerulonephritis	3.43e-05	0.000534	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—APOA1—membranous glomerulonephritis	3.39e-05	0.000528	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL1B—membranous glomerulonephritis	3.38e-05	0.000527	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—APOE—membranous glomerulonephritis	3.23e-05	0.000504	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—APOA1—membranous glomerulonephritis	3.2e-05	0.000498	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—ABCA1—membranous glomerulonephritis	3.06e-05	0.000477	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—ALB—membranous glomerulonephritis	2.95e-05	0.00046	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—TBXAS1—membranous glomerulonephritis	2.88e-05	0.000449	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ABCA1—membranous glomerulonephritis	2.68e-05	0.000418	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—RHOA—membranous glomerulonephritis	2.59e-05	0.000404	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—LRP2—membranous glomerulonephritis	2.56e-05	0.0004	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—ALB—membranous glomerulonephritis	2.53e-05	0.000395	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PLA2G1B—membranous glomerulonephritis	2.47e-05	0.000385	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—APOE—membranous glomerulonephritis	2.34e-05	0.000364	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—APOA1—membranous glomerulonephritis	2.31e-05	0.00036	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MMP9—membranous glomerulonephritis	2.06e-05	0.000321	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—APOE—membranous glomerulonephritis	2.01e-05	0.000314	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—APOA1—membranous glomerulonephritis	1.99e-05	0.00031	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ALB—membranous glomerulonephritis	1.83e-05	0.000285	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—APOE—membranous glomerulonephritis	1.76e-05	0.000275	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—APOA1—membranous glomerulonephritis	1.74e-05	0.000272	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ABCA1—membranous glomerulonephritis	1.65e-05	0.000258	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ALB—membranous glomerulonephritis	1.38e-05	0.000215	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—APOE—membranous glomerulonephritis	1.09e-05	0.000169	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—APOA1—membranous glomerulonephritis	1.07e-05	0.000168	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ALB—membranous glomerulonephritis	8.51e-06	0.000133	CbGpPWpGaD
